The U.S. Food and Drug Administration has approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) for evaluation of men with suspected prostate cancer – the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. This was a rare institutional approval. F-18 fluciclovine and C-11 choline […]
Monthly Archives: December 2020
News Media & Publications
Nadofaragene firadenovec published data show strong efficacy in BCG-unresponsive NMIBC
01
Dec
Dec
Nadofaragene firadenovec induced complete responses (CRs) in over half of patients with high-grade, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), according to phase 3 data Currently, pembrolizumab (Keytruda) and the intravesical treatment nadofaragene firadenovec are at the forefront of therapeutic advances in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). Pembrolizumab was approved in January 2020 for the […]